SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-000453
Filing Date
2020-01-15
Accepted
2020-01-15 10:12:38
Documents
3
Period of Report
2020-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 32285
2 AMENDMENT TO THE COLLABORATIVE RESEARCH AGREEMENT ndra_ex101.htm EX-10.1 32146
3 PRESS RELEASE ndra_ex991.htm EX-99.1 11875
  Complete submission text file 0001654954-20-000453.txt   77583
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 20527416
SIC: 3845 Electromedical & Electrotherapeutic Apparatus